Topical β-Blockers and Mortality

Ophthalmology

Volumn 115, Issue 11, 2008, Pages 2037-2043

  Müskens, Rogier P H M ^a,b   Wolfs, Roger C W ^b   Witteman, Jacqueline C M ^b   Hofman, Albert ^b   de Jong, Paulus T V M ^b,c,d   Stricker, Bruno H C ^b   Jansonius, Nomdo M ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CARDIOVASCULAR SYMPTOM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; SMOKING;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; CHOLESTEROL; FEMALE; GLAUCOMA; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TIMOLOL;

EID: 54949107717     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.07.004     Document Type: Article

References (21)

1. Heijl A., Leske M.C., Bengtsson B., et al., Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120 (2002) 1268-1279
2. Kass M.A., Heuer D.K., Higginbotham E.J., et al., Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713
3. Lee A.J., Wang J.J., Kifley A., and Mitchell P. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology 113 (2006) 1069-1076
4. Domanski M.J., Krause-Steinrauf H., Massie B.M., et al., BEST Investigators. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail 9 (2003) 354-363
5. Krum H. Tolerability of carvedilol in heart failure: clinical trials experience. Am J Cardiol 93 (2004) 58B-63B
6. Lindenauer P.K., Pekow P., Wang K., et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
7. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
8. Hofman A., Breteler M.M., van Duijn C.M., et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol 22 (2007) 819-829
9. Borger P.H., van Leeuwen R., Hulsman C.A., et al. Is there a direct association between age-related eye diseases and mortality?. The Rotterdam Study. Ophthalmology 110 (2003) 1292-1296
10. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Version for 2007. http://www.who.int/classifications/apps/icd.icd100nline/ Accessed February 8, 2008.
11. Ikram M.K., Witteman J.C., Vingerling J.R., et al. Retinal vessel diameters and risk of hypertension: the Rotterdam Study. Hypertension 47 (2006) 189-194
12. Heeringa J., van der Kuip D.A., Hofman A., et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam Study. Eur Heart J 27 (2006) 949-953
13. Bleumink G.S., Knetsch A., Sturkenboom M.C., et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: The Rotterdam Study. Eur Heart J 25 (2004) 1614-1619
14. de Torbal A., Boersma E., Kors J.A., et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J 27 (2006) 729-736
15. Hollander M., Bots M.L., del Sol A.I., et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam Study. Circulation 105 (2002) 2872-2877
16. Maitland-van der Zee A.H., Klungel O.H., Stricker B.C., et al. Repeated nitrate prescriptions as a potential marker for angina pectoris: a comparison with medical information from the Rotterdam Study. Pharm World Sci 25 (2003) 70-72
17. de Voogd S., Ikram M.K., Wolfs R.C., et al. Is diabetes mellitus a risk factor for open-angle glaucoma?. The Rotterdam Study. Ophthalmology 113 (2006) 1827-1831
18. Altman D.G. Practical Statistics for Medical Research (1991), Chapman & Hall, London 349
19. Arnesen E., Thelle D.S., Førde O.H., and Mjøs O.D. Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977. J Epidemiol Community Health 37 (1983) 141-144
20. Gundersen T., Kjekshus J., Stokke O., and Pedersen T. Timolol maleate and HDL cholesterol after myocardial infarction. Eur Heart J 6 (1985) 840-844
21. Statistics Netherlands. http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=7052_95&D1=0-8,29-34,38,42-43,46-52,55-56,62-63,66,69-71,75,79-80,88-91&D2=0&D3=0&D4=37&HDR=G1,G2,G3&STB=T&VW=T Accessed December 2, 2007.